SequelSEC

METLIFE INC MET

Life Insurance · CIK 0001099219 · Fiscal year ends 1231 · Insurer

Revenue
$77.08B
Fiscal year ended 2025-12-31
Net income
$3.38B
Fiscal year ended 2025-12-31
Total assets
$745.17B
Fiscal year ended 2025-12-31

METLIFE INC (MET) reported revenue of $77.08B and net income of $3.38B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from METLIFE INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Life Insurance.

Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.

Income

METLIFE INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$77.08B$70.99B$66.90B$68.77B$68.70B$67.84B$69.62B$67.94B$62.31B$60.79B
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income$6.14B$6.00B$5.72B$5.98BUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net income$3.38B$4.43B$1.58B$5.28B$6.86B$5.41B$5.90B$5.12B$4.01B$850.00M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 673.30Mshares 711.10Mshares 762.30Mshares 808.90Mshares 869.40Mshares 913.20Mshares 944.40Mshares 1.01Bshares 1.08Bshares 1.11B
Pretax income$4.66B$5.62B$2.16B$6.36B$8.52B$6.93B$6.80B$6.31B$3.54B$4.28B
Income tax expense$1.26B$1.18B$560.00M$1.06B$1.64B$1.51B$886.00M$1.18B-$1.47B$693.00M
Diluted EPS$4.71$5.94$1.81$6.30$7.65$5.68$6.06$4.91$3.62$0.67
Selling, general & administrative$7.35B$6.50B$6.65B$5.93B$6.13B$6.36B$6.90B$6.62B$6.52B$6.75B
General & administrative$560.00M$481.00M$828.00M$669.00M$670.00M$761.00M$901.00M$910.00M$1.13B$1.01B
Selling & marketing$6.79B$6.02B$5.82B$5.26B$5.46B$5.60B$6.00B$5.71B$5.39B$5.74B

Balance

METLIFE INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalents$22.03B$20.07B$20.64B$20.20B$20.05B$19.80B$16.60B$15.82B$12.70B$12.65B
Total assets$745.17B$677.46B$687.58B$663.07B$759.71B$795.15B$740.46B$687.54B$719.89B$898.76B
Current assetsUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total liabilities$716.24B$649.75B$657.33B$632.95B$691.96B$720.33B$674.08B$634.58B$661.02B$831.06B
Current liabilitiesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total equity incl. NCI$28.68B$27.70B$30.25B$30.12B$50.01B$74.82B$66.38B$52.96B$58.87B$67.70B
Temporary (mezzanine) equity$241.00M$0UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$0
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$272.00M$238.00M$243.00M$226.00M$235.00M$132.00MUnavailableUnavailableUnavailableUnavailable
Goodwill$9.61B$8.90B$9.24B$9.30B$9.54B$10.11B$9.31B$9.42B$9.59B$9.22B
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

METLIFE INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flow$17.09B$14.60B$13.72B$13.04B$12.35B$11.64B$13.79B$11.74B$12.28B$14.77B
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow-$15.61B-$11.49B-$10.25B-$2.62B-$11.19B-$18.57B-$17.59B-$5.63B-$16.88B-$5.85B
Financing cash flow$163.00M-$3.13B-$2.94B-$9.95B-$1.13B$10.73B$4.57B-$2.80B-$906.00M-$3.50B
Net change in cash$1.96B-$571.00M$444.00M$79.00M-$444.00M$3.96B$777.00M$3.12B-$5.18B$5.12B
Stock-based compensationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common dividends paid$1.51B$1.53B$1.57B$1.60B$1.65B$1.66B$1.64B$1.68B$1.72B$1.74B
Common share repurchases$2.88B$3.21B$3.10B$3.33B$4.30B$1.15B$2.28B$3.99B$2.93B$372.00M
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

METLIFE INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating margin8.0%8.4%8.6%8.7%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratioUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Revenue YoY growth8.6%6.1%-2.7%0.1%1.3%-2.6%2.5%9.0%2.5%Unavailable
Net margin4.4%6.2%2.4%7.7%10.0%8.0%8.5%7.5%6.4%1.4%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate27.0%21.0%25.9%16.7%19.3%21.8%13.0%18.7%-41.6%16.2%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MET in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-19View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-01View SEC filing

Companies in the same industry

Reconciliation checks needing review

5 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

cash flow reconciliationreview2025-12-31

Operating, investing and financing flows differ from the reported change in cash by 316000000, beyond tolerance 170920000.00.

cash flow reconciliationreview2024-12-31

Operating, investing and financing flows differ from the reported change in cash by 545000000, beyond tolerance 145980000.00.

cash flow reconciliationreview2022-12-31

Operating, investing and financing flows differ from the reported change in cash by 397000000, beyond tolerance 130440000.00.

cash flow reconciliationreview2021-12-31

Operating, investing and financing flows differ from the reported change in cash by 478000000, beyond tolerance 123470000.00.

balance equationreview2021-12-31

Difference 17736000000 exceeds tolerance 759708000.000. Presentation or filing-vintage differences need review.